FDA approves pediatric neuroblastoma drug based on Penn State professor's work
December 14, 2023
December 14, 2023
UNIVERSITY PARK, Pennsylvania, Dec. 14 -- Pennsylvania State University issued the following news:
HERSHEY, Pa. -- In 2003, the first year of her fellowship in pediatric oncology, two of Giselle Saulnier Sholler's first three patients had died from neuroblastoma, closely matching the 30% survival rate expected at the time for high-risk neuroblastoma. She knew research was the only way to change these outcomes. Now, 20 years later, the U.S. Food and Drug Administration (FDA) has appr . . .
HERSHEY, Pa. -- In 2003, the first year of her fellowship in pediatric oncology, two of Giselle Saulnier Sholler's first three patients had died from neuroblastoma, closely matching the 30% survival rate expected at the time for high-risk neuroblastoma. She knew research was the only way to change these outcomes. Now, 20 years later, the U.S. Food and Drug Administration (FDA) has appr . . .